Search Results

, paresthesias, and lymphedema). 1 , 2 Currently, there is sufficient evidence to support omission of completion axillary lymph node dissection (CLND) in patients undergoing breast-conserving surgery (BCS) with micrometastatic or macrometastatic disease in up to

occurrence of a pathologic complete response (pCR) after NAC. There has been some variation in how pCR has been defined in the literature, 7 but is generally defined as a lack of all signs of invasive carcinoma in tissue removed by surgery after treatment

patients with stage II–III colon cancer without preoperative obstructing lesions and at least a year of follow-up at the time of data abstraction had a documented colonoscopy within 1 year of surgery. Among patients who had a follow-up colonoscopy, the

size or aggressive histologic subtype. Surgery is recommended for primary BCCs and SCCs, but the recommended surgical approaches differ according to risk category. 20 , 21 We aimed to characterize the clinical features, histology, management, and

: 1944 – 1956 . 10. Sanchez MJ Martinez C Nieto A . Oral and oropharyngeal cancer in Spain: influence of dietary patterns . Eur J Cancer Prev 2003 ; 12 : 49 – 56 . 11. Hicks WL Jr Kuriakose MA Loree TR . Surgery versus radiation

. Sample size calculations were performed using κ size package of the R library. 11 The 61 hospital departments specializing in radiology, medical oncology, radiation oncology, neurosurgery, and orthopedic surgery, which had previously participated in

advanced disease; it results in the downstaging of breast and regional nodal disease burden and facilitates breast conservation and/or less extensive axillary surgery. 2 Upstaging to a higher regional stage or detection of metastatic disease may impact

, therapeutic strategies to maintain bone health, and treatment of bone metastases, including surgery for pathologic fractures. Multiple members of the health care team may be needed for effective patient care and education. This report summarizes presentations

persists despite adjuvant therapy in many patients with breast cancer for up to 4 years after surgery. 14 Reports on the prognostic value of minimal residual disease detection show conflicting results. In a systematic review of published studies, minimal

characteristics (Charlson comorbidity score and regular use of statins and nonsteroidal anti‐inflammatory drugs [NSAIDs], including aspirin), tumor-related characteristics (year of diagnosis, cancer stage, and cancer site), and treatment characteristics (surgery